Clinplex AI is a regulatory intelligence platform that spans the entire drug lifecycle — from discovery and preclinical compliance through clinical trials, GMP manufacturing, regulatory submissions, and post-market pharmacovigilance. Pharmaceutical, biotech, and medical device teams use Clinplex to analyze regulatory documents against FDA, ICH, EMA, and global frameworks — with severity scoring, exact regulatory citations, and remediation roadmaps. Upload documents directly (PDF, Word, Excel) or integrate with platforms like Veeva Vault, MasterControl, TrackWise, SAP QM, clinical trial management systems, and safety databases for continuous monitoring. What makes Clinplex different is cross-domain intelligence. Most compliance tools cover one regulatory domain. Clinplex connects signals across GLP, GCP, GMP, regulatory submissions, and pharmacovigilance — detecting patterns that siloed systems miss. A manufacturing deviation that impacts an NDA timeline. A PV signal that requires labeling changes affecting clinical trial design. A GLP data integrity issue that can unravel an IND submission. Core capabilities include real-time gap analysis across 150+ regulatory frameworks, investigation adequacy scoring, eCTD submission readiness assessment, predictive inspection risk scoring based on actual FDA enforcement data, and pharmacovigilance compliance monitoring. Every document analyzed in approximately 2.4 seconds. Founded in 2023 by Harsh Shah — 16+ years in pharmaceutical quality assurance and regulatory affairs, including leadership at Johnson & Johnson and Leidos Biomedical Research — Clinplex was built to close the gap between how regulatory compliance is managed (in silos, periodically, manually) and how it should work (continuous, AI-powered, cross-domain). Whether you're a pre-IND biotech building regulatory infrastructure from scratch or a global pharma company managing multi-site operations across every lifecycle stage, Clinplex delivers the same depth of regulatory intelligence.